IDEXX Laboratories, Inc.IDXXNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+13.1%
5Y CAGR+13.1%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+13.1%/yr
vs +15.2%/yr prior
5Y CAGR
+13.1%/yr
Consistent
Acceleration
-2.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.47B | +15.1% |
| 2024 | $1.28B | +4.8% |
| 2023 | $1.22B | +20.0% |
| 2022 | $1.01B | -2.4% |
| 2021 | $1.04B | +31.0% |
| 2020 | $793.81M | +23.3% |
| 2019 | $643.68M | +11.8% |
| 2018 | $575.66M | +14.8% |
| 2017 | $501.42M | +16.2% |
| 2016 | $431.69M | - |